NCT05638048 Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients Status COMPLETED Phase NA
NCT05622136 Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05600933 Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment Status ENROLLING_BY_INVITATION Phase N/A
NCT05598268 A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. Status UNKNOWN Phase PHASE1/PHASE2
NCT05540925 Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer Status COMPLETED Phase N/A
NCT05532319 HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC Status COMPLETED Phase PHASE2
NCT05520099 Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05517811 Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection Status RECRUITING Phase N/A
NCT05510427 Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification Status WITHDRAWN Phase PHASE1
NCT05497453 A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene Status TERMINATED Phase PHASE1/PHASE2
NCT05492136 Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? Status RECRUITING Phase NA
NCT05475054 Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes Status COMPLETED Phase N/A
NCT05462314 Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies Status COMPLETED Phase N/A
NCT05444478 Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT05443230 Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment Status UNKNOWN Phase N/A
NCT05443217 Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments Status UNKNOWN Phase N/A